CrossFirst Bankshares Posts Q2 Earnings, Joins Owens & Minor, Reddit And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 40 points on Tuesday.Shares of CrossFirst Bankshares, Inc. (NASDAQ:CFB) fell sharply in today's pre-market trading
Indivior Advances Share Buyback Program
Morgan Stanley Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $25.93
Morgan Stanley analyst Thibault Boutherin maintains $Indivior(INDV.US)$ with a buy rating, and adjusts the target price from $34.37 to $25.93.According to TipRanks data, the analyst has a success
Indivior to Unveil Mid-Year Financial Results
Soligenix SNGX Data; Indivior INDV Forecast Disappoints
Wells Fargo Posts Q2 Earnings, Joins Snowflake And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining around 10 points on Friday.Shares of Wells Fargo & Company (NYSE:WFC) fell sharply in today's pre-market trading after the
Indivior PLC Shares Shift With Oaktree Stake Change
BlackRock Increases Stake in Indivior PLC
Indivior PLC (INDV) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Indivior Is Maintained at Buy by Craig-Hallum
Indivior Is Maintained at Buy by Craig-
Indivior Price Target Cut to $24.00/Share From $37.00 by Craig-Hallum
Indivior Price Target Cut to $24.00/Share From $37.00 by Craig-
Indivior (INDV) Down on Dropping Schizophrenia Drug, Cuts '24 View
This downward revision in guidance by Indivior reflects adverse sales conditions for its top-selling medication, Sublocade, which is approved for treating opioid use disorder.
Indivior Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/10/2024 136.45% Craig-Hallum $37 → $24 Maintains Buy 04/03/2024 264.53% Craig-Hallum → $37 Initiates
Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating, Announces Target Price $24
Craig-Hallum analyst Chase Knickerbocker maintains $Indivior(INDV.US)$ with a buy rating, and sets the target price at $24.According to TipRanks data, the analyst has a success rate of 48.0% and a
Deutsche Numis Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $20.34
Deutsche Numis analyst Paul Cuddon maintains $Indivior(INDV.US)$ with a buy rating, and adjusts the target price from $31.87 to $20.34.According to TipRanks data, the analyst has a success rate of 0.0
Express News | Indivior PLC : Craig-Hallum Cuts Target Price to $24 From $37
Indivior (INDV) Receives a Buy From Deutsche Numis
Why Helen of Troy Shares Are Trading Lower By Around 30%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Helen of Troy Limited (NASDAQ:HELE) fell sharply during Tuesday's session after the company reported soft first-quarter earnings and lowered its FY25 guidance.Helen of Troy reported
Craig-Hallum Initiates Indivior(INDV.US) With Buy Rating
Craig-Hallum analyst Alex Fuhrman initiates coverage on $Indivior(INDV.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 34.9% and a total average return of -4.9%
What's Going On With Addiction And Mental Illnesses-Focused Indivior Stock On Tuesday?
Tuesday, Indivior Plc (NASDAQ:INDV) announced a downward revision of its profit forecast for the year while deciding to cease sales of its schizophrenia drug Perseris.The company also plans to
No Data